Probiotic for Lactose Intolerance

Palo Alto (17 mi)

Overseen byDennis Savaiano, PhD

Age: 18+

Sex: Any

Travel: May be covered

Time Reimbursement: Varies

Trial Phase: N/A

Waitlist Available

Sponsor: Purdue University

Trial Summary

What is the purpose of this trial?This trial aims to see if a special type of beneficial bacteria can help people who have trouble digesting lactose. The bacteria, Bifidobacterium adolescentis IVS-1, is given to participants to see if it can improve their ability to digest dairy products and reduce discomfort. The study focuses on people with lactose intolerance and tests how well this bacteria works in their gut.

Eligibility Criteria

This trial is for adults aged 18-65 who self-report lactose intolerance or maldigestion, can avoid lactose and certain treatments during the study, and are willing to complete all procedures. Excluded are those with severe gastrointestinal conditions, recent surgeries affecting digestion, high BMI (>35), active ulcers, pregnancy, chemotherapy patients, and those with immune diseases.

Inclusion Criteria

I am between 18 and 65 years old.

I am willing and able to give my consent to participate.

Exclusion Criteria

I have active ulcers or a history of severe ulcers.

I am currently receiving chemotherapy.

I regularly use antacids or proton pump inhibitors.

I have diabetes (type 1 or type 2).

I have been diagnosed with congestive heart failure.

I do not have HIV, Hepatitis B, or Hepatitis C.

Treatment Details

The trial tests if a Bifidobacterium adolescentis capsule improves lactose digestion in intolerant individuals compared to a placebo. It aims to see if this probiotic can change the gut microbiome to better handle dairy products.

2Treatment groups

Experimental Treatment

Placebo Group

Group I: Experimental GroupExperimental Treatment1 Intervention

Daily Bifidobacterium adolescentis IVS-1,capsule

Group II: Control GroupPlacebo Group1 Intervention

Daily cellulose capsule